A monoclonal antibody specifically reactive with Ewing's sarcoma

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Ewing's sarcoma (ES) is a challenging pediatric cancer.
• Distinguishing ES from similar small round cell tumors is diagnostically difficult.
• There is a need for specific diagnostic markers and therapeutic targets for ES.

Purpose of the Study:

• To develop and characterize a novel monoclonal antibody for Ewing's sarcoma.
• To assess the antibody's specificity and potential diagnostic and therapeutic applications.

Main Methods:

• Development of a mouse monoclonal antibody (5C11, IgG2a) against ES cell surface antigen.
• Testing antibody reactivity against various pediatric tumors and normal tissues.
• Immunoelectron microscopy and biochemical analysis (immunoprecipitation) to locate and characterize the antigen.

Main Results:

• Antibody 5C11 specifically reacted with Ewing's sarcoma cells.
• It showed no cross-reactivity with neuroblastomas, PNETs, rhabdomyosarcomas, or lymphomas, but did react with hepatoblastomas.
• The target antigen is an 81,000 Da cell surface protein, located on the ES cell membrane.
• No reactivity was observed in normal adult tissues, only in fetal hepatocytes.

Conclusions:

• Antibody 5C11 is a highly specific marker for Ewing's sarcoma, aiding in its differentiation from other small round cell tumors, particularly neurogenic tumors.
• The findings support 5C11's utility in diagnostics and studying ES histogenesis.
• The lack of normal tissue reactivity suggests potential therapeutic applications for 5C11 in managing ES.